An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome

NCT02823145 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Dravet Syndrome

Interventions

DRUG: ZX008 (Fenfluramine Hydrochloride)

Sponsor

Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.